LRGUK
gene geneOn this page
Also known as FLJ32786CFAP246
Summary
LRGUK (leucine rich repeats and guanylate kinase domain containing, HGNC:21964) is a protein-coding gene on chromosome 7q33, encoding Leucine-rich repeat and guanylate kinase domain-containing protein (Q96M69). Involved in multiple aspects of sperm assembly including acrosome attachment, shaping of the sperm head and in the early aspects of axoneme development.
Predicted to enable guanylate kinase activity. Predicted to be involved in axoneme assembly and spermatogenesis. Predicted to be located in acrosomal vesicle and manchette. Predicted to be active in cytosol.
Source: NCBI Gene 136332 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 133 total
- MANE Select transcript:
NM_144648
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21964 |
| Approved symbol | LRGUK |
| Name | leucine rich repeats and guanylate kinase domain containing |
| Location | 7q33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32786, CFAP246 |
| Ensembl gene | ENSG00000155530 |
| Ensembl biotype | protein_coding |
| OMIM | 616478 |
| Entrez | 136332 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000285928, ENST00000473068, ENST00000645682, ENST00000695542, ENST00000695543
RefSeq mRNA: 4 — MANE Select: NM_144648
NM_001365700, NM_001365701, NM_001401519, NM_144648
CCDS: CCDS5830, CCDS94203, CCDS94204
Canonical transcript exons
ENST00000285928 — 20 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000833228 | 134163397 | 134163540 |
| ENSE00001021343 | 134158035 | 134158159 |
| ENSE00001021349 | 134174556 | 134174636 |
| ENSE00001021350 | 134178503 | 134178609 |
| ENSE00001021351 | 134176977 | 134177063 |
| ENSE00001021352 | 134183734 | 134183853 |
| ENSE00001021353 | 134191655 | 134191751 |
| ENSE00001021360 | 134258257 | 134258405 |
| ENSE00001086571 | 134143062 | 134143162 |
| ENSE00001086572 | 134248951 | 134249076 |
| ENSE00001086579 | 134247556 | 134247644 |
| ENSE00001086580 | 134148238 | 134148319 |
| ENSE00001086581 | 134221779 | 134221918 |
| ENSE00001175610 | 134201481 | 134201576 |
| ENSE00001175613 | 134199220 | 134199421 |
| ENSE00001175617 | 134196992 | 134197105 |
| ENSE00001292305 | 134263845 | 134264595 |
| ENSE00003499047 | 134137023 | 134137130 |
| ENSE00003613525 | 134139436 | 134139517 |
| ENSE00003964227 | 134127340 | 134127664 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 83.36.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3930 / max 34.2825, expressed in 160 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 81252 | 0.3930 | 160 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 83.36 | gold quality |
| bronchus | UBERON:0002185 | 82.04 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.78 | gold quality |
| sperm | CL:0000019 | 76.45 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 75.42 | gold quality |
| right uterine tube | UBERON:0001302 | 73.32 | gold quality |
| oviduct epithelium | UBERON:0004804 | 72.75 | gold quality |
| buccal mucosa cell | CL:0002336 | 72.51 | gold quality |
| pancreatic ductal cell | CL:0002079 | 71.68 | silver quality |
| tibialis anterior | UBERON:0001385 | 69.13 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 67.69 | gold quality |
| left testis | UBERON:0004533 | 67.57 | gold quality |
| testis | UBERON:0000473 | 67.32 | gold quality |
| ventricular zone | UBERON:0003053 | 66.71 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 66.26 | gold quality |
| right testis | UBERON:0004534 | 66.11 | gold quality |
| fallopian tube | UBERON:0003889 | 65.45 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 65.32 | silver quality |
| ileal mucosa | UBERON:0000331 | 63.44 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 62.66 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 62.60 | gold quality |
| bone marrow cell | CL:0002092 | 61.60 | gold quality |
| granulocyte | CL:0000094 | 60.20 | gold quality |
| ganglionic eminence | UBERON:0004023 | 59.68 | gold quality |
| deltoid | UBERON:0001476 | 59.42 | silver quality |
| cortical plate | UBERON:0005343 | 59.23 | gold quality |
| body of pancreas | UBERON:0001150 | 57.71 | gold quality |
| caput epididymis | UBERON:0004358 | 56.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 56.82 | gold quality |
| metanephros cortex | UBERON:0010533 | 56.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.38 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting LRGUK, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-4506 | 99.34 | 67.47 | 526 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-3064-5P | 99.26 | 66.13 | 1497 |
| HSA-MIR-3085-3P | 99.26 | 66.16 | 1490 |
| HSA-MIR-6504-5P | 99.26 | 65.95 | 1487 |
| HSA-MIR-3940-5P | 99.14 | 65.26 | 493 |
| HSA-MIR-4507 | 99.14 | 65.27 | 515 |
| HSA-MIR-6809-5P | 99.13 | 68.45 | 1223 |
| HSA-MIR-922 | 99.02 | 67.23 | 1838 |
| HSA-MIR-1207-3P | 98.99 | 66.22 | 1532 |
| HSA-MIR-4716-5P | 98.82 | 68.57 | 1168 |
| HSA-MIR-4736 | 97.96 | 65.89 | 1287 |
| HSA-MIR-1258 | 96.08 | 67.74 | 700 |
Literature-anchored findings (GeneRIF, showing 2)
- Study demonstrates that leucine-rich repeats and guanylate kinase-domain containing isoform 1 (LRGUK-1) is required for multiple aspects of sperm assembly, including acrosome attachment, sperm head shaping and the initiation of the axoneme growth to form the core of the sperm tail. (PMID:25781171)
- The structure revealed that hGMPK consists of three distinct regions designated as the LID, GMP-binding (GMP-BD), and CORE domains and is in an open configuration that is nucleotide binding-competent. Nonsynonymous single-nucleotide variants of the hGMPK CORE domain distant from the nucleotide-binding site of this domain modulate enzymatic activity without significantly affecting hGMPK’s structure. (PMID:31201273)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | lrguk | ENSDARG00000069698 |
| mus_musculus | Lrguk | ENSMUSG00000056215 |
| rattus_norvegicus | Lrguk | ENSRNOG00000008775 |
| drosophila_melanogaster | TbCMF46 | FBGN0032163 |
| drosophila_melanogaster | Ppr-Y | FBGN0046697 |
Paralogs (13): LRRC23 (ENSG00000010626), LRRC61 (ENSG00000127399), DNAAF11 (ENSG00000129295), LRRC9 (ENSG00000131951), LRRCC1 (ENSG00000133739), LRRC49 (ENSG00000137821), LRRC46 (ENSG00000141294), DNAAF1 (ENSG00000154099), LRRC43 (ENSG00000158113), LRRIQ3 (ENSG00000162620), DRC3 (ENSG00000171962), PPP1R42 (ENSG00000178125), CEP97 (ENSG00000182504)
Protein
Protein identifiers
Leucine-rich repeat and guanylate kinase domain-containing protein — Q96M69 (reviewed: Q96M69)
All UniProt accessions (4): Q96M69, A0A2R8YEJ5, A0A8Q3SI13, A0A8Q3SIT3
UniProt curated annotations — full annotation on UniProt →
Function. Involved in multiple aspects of sperm assembly including acrosome attachment, shaping of the sperm head and in the early aspects of axoneme development. Not essential for primary cilium biogenesis.
Subunit / interactions. Interacts (via guanylate kinase-like domain) with RIMBP3 (via coiled-coil region). Interacts (via guanylate kinase-like domain) with HOOK2. Interacts (via LRRCT domain) with KLC3. Interacts with HOOK1 and HOOK3.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome. Cytoplasm. Cytoskeleton. Cilium basal body.
RefSeq proteins (4): NP_001352629, NP_001352630, NP_001388448, NP_653249* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR008144 | Guanylate_kin-like_dom | Domain |
| IPR008145 | GK/Ca_channel_bsu | Domain |
| IPR025875 | Leu-rich_rpt_4 | Repeat |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
Pfam: PF00625, PF12799, PF14580
UniProt features (20 total): repeat 9, domain 2, region of interest 2, compositionally biased region 2, sequence variant 2, chain 1, binding site 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96M69-F1 | 70.42 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 421–428
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 76 (showing top):
GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS, GOCC_SECRETORY_GRANULE, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_MALE_GAMETE_GENERATION, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, BRN2_01, GOBP_CILIUM_ORGANIZATION, GATA6_01, GOBP_ORGANELLE_ASSEMBLY, GOBP_MICROTUBULE_BUNDLE_FORMATION, GATA1_03, NKX25_01, GOBP_GDP_METABOLIC_PROCESS, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION
GO Biological Process (5): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), axoneme assembly (GO:0035082), GMP metabolic process (GO:0046037), GDP metabolic process (GO:0046710)
GO Molecular Function (6): GMP kinase activity (GO:0004385), ATP binding (GO:0005524), nucleotide binding (GO:0000166), protein binding (GO:0005515), kinase activity (GO:0016301), transferase activity (GO:0016740)
GO Cellular Component (7): acrosomal vesicle (GO:0001669), manchette (GO:0002177), cytosol (GO:0005829), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cytoplasmic vesicle (GO:0031410), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| purine ribonucleotide metabolic process | 2 |
| cytoplasm | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| microtubule bundle formation | 1 |
| cellular component assembly | 1 |
| cilium assembly | 1 |
| purine ribonucleoside monophosphate metabolic process | 1 |
| purine ribonucleoside diphosphate metabolic process | 1 |
| GMP metabolic process | 1 |
| GDP metabolic process | 1 |
| nucleoside monophosphate kinase activity | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| transferase activity, transferring phosphorus-containing groups | 1 |
| catalytic activity | 1 |
| secretory granule | 1 |
| microtubule cytoskeleton | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
6169 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRGUK | SPEF2 | Q9C093 | 589 |
| LRGUK | SVOPL | Q8N434 | 572 |
| LRGUK | SSMEM1 | Q8WWF3 | 564 |
| LRGUK | NAT9 | Q9BTE0 | 561 |
| LRGUK | WDR62 | O43379 | 528 |
| LRGUK | HOOK1 | Q9UJC3 | 526 |
| LRGUK | C18orf63 | Q68DL7 | 507 |
| LRGUK | CFAP99 | D6REC4 | 495 |
| LRGUK | COQ9 | O75208 | 493 |
| LRGUK | RAD51AP1 | Q96B01 | 490 |
| LRGUK | TSSK4 | Q6SA08 | 490 |
| LRGUK | NEU2 | Q9Y3R4 | 488 |
| LRGUK | MORN3 | Q6PF18 | 488 |
| LRGUK | CCDC40 | Q4G0X9 | 482 |
| LRGUK | SPACA1 | Q9HBV2 | 480 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HOOK2 | LRGUK | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRGUK | psi-mi:“MI:0915”(physical association) | 0.400 | |
| PB2 | psi-mi:“MI:0914”(association) | 0.350 | |
| LRGUK | HOOK2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): LRGUK (Two-hybrid), LRGUK (Affinity Capture-MS)
ESM2 similar proteins: A0A494C086, A0A494C0Z2, A0A494C191, A0JPH4, A6NHP3, A6NIY4, A6NJR5, A6NLX3, A6NNV3, A6QLI5, B0BNE4, O08918, O60543, O70302, O75916, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, P24864, P39949, P49805, Q12967, Q495Y7, Q495Y8, Q4VXA5, Q4ZIN3, Q5IBH6, Q5IBH7, Q5MJ70, Q5SYB0, Q5XIQ2, Q5ZJR9, Q61457, Q6AYG1
Diamond homologs: B6CZ40, B6CZ45, B6CZ54, B6CZ61, O35125, O43822, P34390, P39687, P51122, P97822, Q28CU0, Q28XE2, Q32KP2, Q3SZC6, Q4WV66, Q53EV4, Q5BGW9, Q5EAD8, Q5F4A3, Q5XIE0, Q6A1I3, Q6PAF6, Q7ZUP0, Q7ZY40, Q8C6G1, Q8HY67, Q8K375, Q92688, Q96E66, Q96M69, Q9BTT0, Q9DAK8, Q9NJE9, Q9V895, Q64520, Q7U570, Q9D5S7, Q16774, Q9KNM4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
133 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 110 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4222 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:134127662:G:GT | donor_gain | 1.0000 |
| 7:134137010:G:A | acceptor_gain | 1.0000 |
| 7:134137131:G:GG | donor_gain | 1.0000 |
| 7:134139431:CTCAG:C | acceptor_loss | 1.0000 |
| 7:134139433:CAGG:C | acceptor_loss | 1.0000 |
| 7:134139434:A:AG | acceptor_gain | 1.0000 |
| 7:134139434:AG:A | acceptor_gain | 1.0000 |
| 7:134139435:G:A | acceptor_loss | 1.0000 |
| 7:134139435:G:GG | acceptor_gain | 1.0000 |
| 7:134139435:GG:G | acceptor_gain | 1.0000 |
| 7:134139435:GGGTT:G | acceptor_gain | 1.0000 |
| 7:134139513:TGAAG:T | donor_loss | 1.0000 |
| 7:134139514:GAAGG:G | donor_loss | 1.0000 |
| 7:134139517:GGT:G | donor_loss | 1.0000 |
| 7:134139518:GTAT:G | donor_loss | 1.0000 |
| 7:134139519:T:G | donor_loss | 1.0000 |
| 7:134163392:TTTA:T | acceptor_loss | 1.0000 |
| 7:134163393:TTA:T | acceptor_loss | 1.0000 |
| 7:134163394:TA:T | acceptor_loss | 1.0000 |
| 7:134163395:A:AG | acceptor_gain | 1.0000 |
| 7:134163396:G:GA | acceptor_gain | 1.0000 |
| 7:134163396:GA:G | acceptor_gain | 1.0000 |
| 7:134163396:GAGC:G | acceptor_gain | 1.0000 |
| 7:134163396:GAGCA:G | acceptor_gain | 1.0000 |
| 7:134163514:G:GT | donor_gain | 1.0000 |
| 7:134163532:GATAA:G | donor_gain | 1.0000 |
| 7:134163536:ATAAG:A | donor_loss | 1.0000 |
| 7:134163537:TAAGG:T | donor_loss | 1.0000 |
| 7:134163538:AAGGT:A | donor_loss | 1.0000 |
| 7:134163539:AGG:A | donor_loss | 1.0000 |
AlphaMissense
5437 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:134143101:T:C | L176P | 0.995 |
| 7:134183781:G:A | G421D | 0.995 |
| 7:134197035:G:A | G492E | 0.995 |
| 7:134199220:G:C | G516R | 0.995 |
| 7:134163461:T:C | L287P | 0.994 |
| 7:134163527:T:C | L309P | 0.994 |
| 7:134183780:G:C | G421R | 0.994 |
| 7:134191713:T:C | F465L | 0.994 |
| 7:134191715:T:A | F465L | 0.994 |
| 7:134191715:T:G | F465L | 0.994 |
| 7:134196999:T:C | F480S | 0.994 |
| 7:134199266:T:C | L531P | 0.994 |
| 7:134148308:T:C | L220P | 0.993 |
| 7:134158089:T:C | L242P | 0.993 |
| 7:134177032:T:C | L359S | 0.993 |
| 7:134196992:G:T | G478W | 0.993 |
| 7:134143158:T:C | L195P | 0.992 |
| 7:134174611:T:C | L332P | 0.992 |
| 7:134174617:T:C | L334P | 0.992 |
| 7:134197082:A:C | S508R | 0.992 |
| 7:134197084:C:A | S508R | 0.992 |
| 7:134197084:C:G | S508R | 0.992 |
| 7:134143092:T:A | L173H | 0.991 |
| 7:134143092:T:C | L173P | 0.991 |
| 7:134174605:G:C | R330P | 0.991 |
| 7:134177023:T:C | L356S | 0.991 |
| 7:134196993:G:T | G478V | 0.991 |
| 7:134143158:T:A | L195H | 0.990 |
| 7:134178509:G:C | A372P | 0.990 |
| 7:134191672:G:C | R451T | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000000136 (7:134259955 G>A), RS1000031189 (7:134142672 A>G), RS1000059334 (7:134130547 G>A,C), RS1000088897 (7:134215210 C>T), RS1000103373 (7:134184371 A>C), RS1000129307 (7:134159021 G>A,T), RS1000155850 (7:134274648 T>C), RS1000160584 (7:134209311 A>G), RS1000182974 (7:134258086 A>G), RS1000204836 (7:134266097 A>G), RS1000217419 (7:134276264 A>T), RS1000238108 (7:134255425 T>A,C), RS1000244311 (7:134159260 C>T), RS1000248216 (7:134267935 T>A), RS1000274106 (7:134202392 G>A)
Disease associations
OMIM: gene MIM:616478 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005024_74 | Pursuit maintenance gain | 4.000000e-06 |
| GCST007326_27 | Number of sexual partners | 6.000000e-11 |
| GCST007327_80 | Smoking status (ever vs never smokers) | 5.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008433 | pursuit maintenance gain measurement |
| EFO:0004318 | smoking behavior |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| bisphenol A | affects methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| abrine | increases expression | 1 |
| licochalcone B | decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Malathion | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.